Edwards Lifesciences Corp

$71.87
(as of Apr 1, 7:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Edwards Lifesciences Corp

Stock Price
$71.87
Ticker Symbol
EW
Exchange
NYSE

Industry Information for Edwards Lifesciences Corp

Sector
Healthcare
Industry
Medical Devices

Company Description for Edwards Lifesciences Corp

Country
USA
Full Time Employees
15,800

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Fundamentals for Edwards Lifesciences Corp

Market Capitalization
$41,535,889,408
EBITDA
$1,635,900,032
Dividends per Share
P/E Ratio
30.3
Forward P/E Ratio
29.24
Earnings per Share
$2.34
Earnings per Share Estimate Next Year
Profit Margin
76.75%
Shares Outstanding
585,755,008
Percent Owned by Insiders
0.90%
Percent Owned by Institutions
88.97%
52-Week High
52-Week Low

Technical Indicators for Edwards Lifesciences Corp

50-Day Moving Average
200-Day Moving Average
RSI
57.87
1.63

Analyst Ratings for Edwards Lifesciences Corp

Strong Buy
9
Buy
5
Hold
19
Sell
0
Strong Sell
0

News About Edwards Lifesciences Corp

Apr 1, 2025, 9:18 AM EST
Sands Capital, an investment management company, released its “Sands Capital Select Growth Fund” Q4 2024 investor letter. See more.
Mar 31, 2025, 2:00 PM EST
CHICAGO, March 31, 2025--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced new scientific evidence presented and published during the American College of Cardiology’s (ACC) Annual Scientific Session & Expo, addressing the critical needs of patients with structural heart disease. See more.
Mar 31, 2025, 9:43 AM EST
We recently published a list of Jim Cramer Put These 16 Stocks Under a Microscope. See more.
Mar 10, 2025, 3:17 PM EST
We recently published an article titled Top 12 Stocks to Buy According to Citadel Investment Group.In this article, we are going to take a look at where Edwards Lifesciences Corporation (NYSE:EW) stands against the other stocks. See more.